Oppenheimer Asset Management Inc. Biolife Solutions Inc Transaction History
Oppenheimer Asset Management Inc.
- $7.62 Billion
- Q2 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 33,296 shares of BLFS stock, worth $833,398. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,296
Previous 18,044
84.53%
Holding current value
$833,398
Previous $334,000
113.47%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BLFS
# of Institutions
169Shares Held
46.4MCall Options Held
11.6KPut Options Held
800-
Casdin Capital, LLC New York, NY8.71MShares$218 Million16.16% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$137 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$83.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$69.7 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$39.5 Million0.17% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.07B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...